5Kidney Disease Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical practice guideline for glomerulonephritis[J].Kidney International,2012,(02):143-153.
6Polanco N,Gutierrez E,Covarsi A. Spontaneous remissin of nepnrotic syndrome in idiopathic membranous nephropathy[J].Journal of the American Society of Nephrology,2010,(04):697-704.
7Hiadunewich MA,Troyanov S,Calafati J. The natural history of the non-nephrotic membranous nepnropathy[J].Clin J Am Soc Nephrol,2009,(09):1417-1422.
8Heymann W,Hackel DB,Harwood S. Production of nephritic syndrome in rats by Freund' s adjuvants and rat kidney suspension[J].Proceedings of the Society for Experimental Biology and Medicine,1959,(04):660-664.
9Ronco P,Debiec H. Antigen identification in membraous nephropathy moves toward targeted monitoring and new therapy[J].Journal of the American Society of Nephrology,2010,(04):564-569.
10Debiec H,Guigonis V,Mougenot B. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies[J].New England Journal of Medicine,2002,(26):2053-2060.
